Vaccine stands for a preparation of dead, attenuate or else modified viruses, bacteria and other microorganisms utilized as an inoculation to immunize against any disease by way of stimulating antibodies’ production. With constant technology upgrades and launches of new medicinal products, Vaccines proved to be the most sophisticated healthcare aid ever created in the pharma’s history.
The global Vaccine Industry is thriving mainly owing to the chronic availability of different diseases, both already-existing and cropping up on the horizon, which can be luckily prevented with Vaccines’ assistance. Pediatric Vaccines form the largest and the most hastily evolving segment as against adult Vaccines, with the trend predicted to stay unaltered in the impending period. The worldwide Vaccine Market is primarily in the paws of such behemoths as Merck & Company, Inc.; Novartis, Pfizer, Inc.; GlaxoSmithKline plc; and Sanofi Pasteur.
The research reports under this Catalogue provide in-depth assessments of the global Vaccine Industry, discussing pressing market issues and statistical figures. The research reports cover the sizing (value/volume) and short-to-long-run forecasts for the overall Vaccine Market and its major segments, and for numerous geographic markets. The listing of M&As among the Vaccine universe participants with new products’ reviews, alongside company profile information can be derived from the research reports too.
Publications found:
866
Sort by:
Personalized Cancer Vaccines Market Forecasts to 2034 – Global Analysis By Vaccine Type (Neoantigen-based Vaccines, Dendritic Cell Vaccines, mRNA-based Vaccines, Peptide-based Vaccines, DNA-based Vaccines, Tumor Cell Vaccines, and Other Vaccine Types), Delivery Method, Technology, Application, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Personalized Cancer Vaccines Market is accounted for $1.4 billion in 2026 and is expected to reach $9.8 billion by 2034 growing at a CAGR of 27.4% during the f...
April 2026
200 pages
Travel Vaccines Market Report by Composition (Mono Vaccines, Combination Vaccines), Disease (Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, and Others), and Region 2026-2034
US$ 3,999.00
The global travel vaccines market size reached USD 4.9 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 10.5 Billion by 2034, exhibiting a growth rate (CAGR) of 8.63% duri...
April 2026
140 pages
Pediatric Vaccines Market Report by Type (Multivalent, Monovalent), Technology (Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid, and Others), Application (Infectious Disease, Cancer, Allergy, and Others), and Region 2026-2034
US$ 3,999.00
The global pediatric vaccines market size reached USD 42.4 Billion in 2025 . Looking forward, IMARC Group expects the market to reach USD 75.1 Billion by 2034 , exhibiting a growth rate (CAGR) of 6.35...
April 2026
143 pages
Therapeutic Vaccines Market Report by Type (Antigen Vaccines, Dendritic Cell Vaccine, DNA Vaccine, Tumor Cell Vaccines), Disease Type (Autoimmune Disease Vaccines, Addiction Vaccines, Neurological Disease Vaccine, Infectious Disease Vaccine, and Others), Technology (Autologous Vaccines, Allogeneic Vaccine), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2026-2034
US$ 3,999.00
The global therapeutic vaccines market size reached USD 37.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 78.5 Billion by 2034, exhibiting a growth rate (CAGR) of 8.32...
April 2026
137 pages
Cholera Vaccines Market Report by Vaccine Type (Whole Cell V. Cholerae O1 with Recombinant B-Subunit, Killed Oral O1 and O139), Product (Dukoral, Shanchol, Vaxchora, Euvichol and Euvichol-Plus, and Others), End User (Hospitals and Clinics, Research and Academic Laboratories, and Others), and Region 2026-2034
US$ 3,999.00
The global cholera vaccines market size reached USD 6.5 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 14.3 Million by 2034, exhibiting a growth rate (CAGR) of 8.85% dur...
April 2026
138 pages
Influenza Diagnostics Market Report by Product (Test Kit and Reagents, Instruments, and Others), Test Type (Molecular Diagnostic Tests, Traditional Diagnostic Tests), Type of Flu (Type A Flu, Type B Flu, Type C Flu), End User (Hospitals, Diagnostic Laboratories, and Others), and Region ?2026-2034?
US$ 3,999.00
The global influenza diagnostics market size reached USD 1,066.5 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,668.0 Million by 2034, exhibiting a growth rate (CAGR)...
April 2026
142 pages
Cancer Vaccines Market Report by Type, (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines), Technology (Dendritic Cells Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Viral Vector and DNA Cancer Vaccines, Whole-cell Cancer Vaccines), Indication (Cervical Cancer, Prostate Cancer, and Others), End User (Pediatrics, Adults), and Region 2026-2034
US$ 3,999.00
The global cancer vaccines market size reached USD 8.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 19.4 Billion by 2034, exhibiting a growth rate (CAGR) of 9.62% duri...
April 2026
138 pages
Meningococcal Vaccines Market Report by Vaccine Type (Conjugate, Polysaccharide, Subcapsular), Composition (Mono Vaccines, Combination Vaccines), Vaccine Serotype (MenACWY, MenB & Manic, MenC, MenA, MenAC, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Institutional Sales, and Others), End User (Pediatric, Adult), and Region 2026-2034
US$ 3,999.00
The global meningococcal vaccines market size reached USD 4.2 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 7.8 Billion by 2034, exhibiting a growth rate (CAGR) of 7.01...
April 2026
138 pages
Global Bladder Cancer Vaccines Market - 2025-2033
US$ 2,999.00
The Global Bladder Cancer Vaccines Market was valued at US$ 201.13 million in 2025 and is anticipated to reach US$ 1,365.83 million by 2033, at a CAGR of 0.2599 from 2026 to 2032. The report delivers...
March 2026
189 pages
Global Digital Vaccine Data Loggers Market Growth 2026-2032
US$ 3,660.00
The global Digital Vaccine Data Loggers market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. The global pharmaceuti...
March 2026
142 pages
Global Vaccine Labeling Machine Market Growth 2026-2032
US$ 3,660.00
The global Vaccine Labeling Machine market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. The global pharmaceutical...
March 2026
113 pages
Global Coccidiosis Vaccines Market Growth 2026-2032
US$ 3,660.00
The global Coccidiosis Vaccines market size is predicted to grow from US$ 172 million in 2025 to US$ 241 million in 2032; it is expected to grow at a CAGR of 5.0% from 2026 to 2032. Coccidiosis vaccin...
March 2026
124 pages
Global Medications for Smallpox Market Growth 2026-2032
US$ 3,660.00
The global Medications for Smallpox market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Medications for smallpox r...
March 2026
85 pages
Global Rotavirus Vaccine Market Growth 2026-2032
US$ 3,660.00
The global Rotavirus Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. The rotavirus vaccine is a vaccin...
March 2026
80 pages
North America Travel Vaccines Market Report by Composition (Mono Vaccines, Combination Vaccines), Disease (Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, and Others), and Country 2026-2034
US$ 3,999.00
The North America travel vaccines market size reached USD 2.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 3.5 Billion by 2034, exhibiting a growth rate (CAGR) of 5.33...
March 2026
140 pages
Global Animal Parvovirus Vaccine Market Growth 2026-2032
US$ 3,660.00
The global Animal Parvovirus Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. United States market for...
February 2026
127 pages
Global Pet Contraceptive Vaccine Market Growth 2026-2032
US$ 3,660.00
The global Pet Contraceptive Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. United States market for...
February 2026
80 pages
